.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 8,263,119

« Back to Dashboard

Details for Patent: 8,263,119

Title:Capsule formulations containing lanthanum compounds
Abstract: The present invention includes an oral pharmaceutical capsule comprising a shell, lanthanum carbonate or lanthanum carbonate hydrate, and a lubricant such as talc, wherein the shell encapsulates the lanthanum carbonate or lanthanum hydrate and the lubricant. Capsule shells comprise, for example, gelatin. The capsules of the present invention dissolve at a similar rate before and after storage. The oral pharmaceutical capsules of the present invention can be administered to treat a patient at risk for or suffering from hyperphosphatemia, at risk for or suffering from chronic kidney disease (CKD), at risk for or suffering from soft tissue calcification associated with CKD, or at risk for or suffering from secondary hyperparathyroidism.
Inventor(s): Withington; Roger (Surrey, GB)
Assignee: Shire LLC (Florence, KY)
Filing Date:Dec 01, 2010
Application Number:12/958,380
Claims:1. An oral pharmaceutical capsule comprising a shell, lanthanum carbonate or lanthanum carbonate hydrate, and talc in an amount from about 0.01% to about 0.05% by weight of the capsule contents, wherein the shell encapsulates the lanthanum carbonate or lanthanum hydrate and the talc.

2. The capsule of claim 1, wherein the shell comprises gelatin.

3. The capsule of claim 2, wherein the gelatin is in an amount from about 10% to about 95% by weight of the shell.

4. The capsule of claim 1, wherein after the capsule is stored at 50.degree. C. or 60.degree. C. for 1 or 2 weeks, the lanthanum carbonate or lanthanum carbonate hydrate of the capsule is at least 80% dissolved after 30 minutes in 0.25 M HCl.

5. The capsule of claim 1, wherein the lanthanum carbonate or lanthanum carbonate hydrate has the formula: La.sub.2(CO.sub.3).sub.3.nH.sub.2O wherein n has a value from 0 to 10.

6. The capsule of claim 5, wherein n has a value from 3 to 6.

7. The capsule of claim 1, wherein the lanthanum carbonate or lanthanum carbonate hydrate is in an amount from about 50% to about 95% by weight of the capsule contents.

8. The capsule of claim 1, further comprising a diluent encapsulated in the shell.

9. The capsule of claim 8, wherein the diluent is dextrates.

10. The capsule of claim 8, wherein the diluent is in an amount from about 5% to about 50% by weight of the capsule contents.

11. The capsule of claim 1, further comprising a flow aid encapsulated in the shell.

12. The capsule of claim 11, wherein the flow aid is colloidal silicon dioxide.

13. The capsule of claim 1, wherein the flow aid is in an amount from about 0.1% to about 4.0% by weight of the capsule contents.

14. The capsule of claim 1, further comprising a disintegrant encapsulated in the shell.

15. The capsule of claim 14, wherein the disintegrant is in an amount from about 1.0% to about 15% by weight of the capsule contents.

16. The capsule of claim 1 comprising (1) 86.7 wt % lanthanum carbonate hydrate, (2) 8.2 wt % dextrates, (3) 1.0 wt % colloidal silicon dioxide, (4) 4.0 wt % crospovidone, and (5) 0.025 wt % talc, wherein the shell encapsulates the lanthanum carbonate hydrate, dextrates, colloidal silicon dioxide, crospovidone, and talc and the weight percentages are based on the weight of the capsule contents.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc